Genomines | $45,000,000 | (Sep 18, 2025)
Synthesize Bio | $10,000,000 | (Sep 18, 2025)
Moby | $5,000,000 | (Sep 18, 2025)
Certified by Founder
Lodge
Brixton Biosciences
start up
United States
- Cambridge, MA
- 15/05/2024
- Series B
- $33,000,000
Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for chronic and acute pain.
- Industry Biotechnology Research
- Website https://www.brixtonbio.com/
- LinkedIn https://www.linkedin.com/company/brixtonbiosciences/
Invisible Technologies | $100,000,000 | (Sep 18, 2025)
Mueon Corporation | $15,500,000 | (Sep 18, 2025)
Stablecore | $20,000,000 | (Sep 18, 2025)
Envive AI | $15,000,000 | (Sep 18, 2025)
Markup AI | $27,500,000 | (Sep 18, 2025)
Turnout | $21,000,000 | (Sep 18, 2025)
GridStrong | $10,000,000 | (Sep 18, 2025)
Imagine Pediatrics | $67,000,000 | (Sep 18, 2025)
Rec Technologies | $11,000,000 | (Sep 18, 2025)